Morning Briefing
Summaries of health policy coverage from major news organizations
Perspectives: Gene Therapy's Cost Is Inaccessible For Many; Do Weight-Loss Drugs Harm Mental Health?
Read recent commentaries about pharmaceutical issues.
The New York Times: Gene Therapies Could Transform Rare Diseases. Are We Holding Them Back?
Gene therapies cost, on average, $1 million to $2 million. At $3.2 million per patient, Elevidys is the second-most-expensive drug in the world. (Elizabeth Currid-Halkett, 2/19)
Stat: What Do Weight Loss Drugs Actually Mean For Mental Health?
Mental illness can cause or worsen obesity, and obesity can cause or worsen mental illness. As an endocrinologist (Jody) and a psychiatrist (Karen), we know this connection better than most people, so we have long checked in with each other to help our mutual patients. (Jody Dushay and Karen S. Greenberg, 2/19)
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
